February 10, 2026 · Form 4 insider transaction
Cherington Charles bought 4,000,000 shares of Ernexa Therapeutics Inc. at $0.50 per share, a transaction worth $2.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.
These shares and warrants were purchased by the reporting person in the Issuer's follow-on offering pursuant to a prospectus supplement dated February 6, 2026, which closed on February 10, 2026.; The combined purchase price in the Offering per share of Common Stock and accompanying warrant was $0.50.